construct, live M. tuberculosis increased transcription 20-fold in THP-1 cells, and cell wall components stimulated CAT expression to a lesser extent. The nuclear factor-KB enhancer element was responsible for the majority of the increased CAT activity although two upstream nuclear factor-IL6 sites may also contribute to enhanced transcription. Antibodies to TNF-a and IL-1 inhibited the increase in CAT activity of the HIV-1 long terminal repeat by M. tuberculosis from 21-fold to 8-fold. Stimulation of HIV-1 replication by M. tuberculosis may exacerbate dysfunction of the host immune response in dually infected individuals. (J. Clin. Invest. 1995Invest. . 95:2324Invest. -2331
Introduction
Tuberculosis has emerged as an epidemic since its steady de- cline began to plateau in 1985 resulting in an excess of 60,000 cases by 1992 compared to the numbers expected if the decline had continued ( 1-3 ). The tuberculosis epidemic has been concentrated in inner cities, e.g., cities > 100,000 with 26% of the United States population account for 53% of tuberculosis morbidity (4) . There is a striking correlation between the epidemiology of AIDS and tuberculosis: cities with the highest AIDS case rates also have the highest rates of tuberculosis, e.g.,
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Receivedforpublication I June 1994 and in revisedform 30 November 1994. matches of AIDS case registries with reported tuberculosis cases have found 12% of AIDS patients infected with Mycobacterium tuberculosis and 40% of tuberculosis patients infected with HIV-1 (3, 5, 6) . Selwyn et al. (7) has demonstrated a striking risk of 11% per year for developing active tuberculosis among HIV positive, purified protein derivative-positive injecting drug users enrolled in a methadone maintenance program compared to the 10% lifetime risk in purified protein derivativepositive individuals without HIV-1 infection. HIV-1 infected individuals have a high likelihood of developing progressive pulmonary and/or extrapulmonary tuberculosis upon new infection with M. tuberculosis. (8, 9) . Tuberculosis has recently been added to the case definition of AIDS. As HIV-1 infection progresses and CD4+ T lymphocytes decline in number, there is a concomitant increase in the percentage of patients with extrapulmonary tuberculosis and mycobacteremia (10) .
Tuberculosis may well accelerate the course of HIV infection (8, 11, 12) . Mortality of dually infected HIV/tuberculosis individuals has been reported to be as high as 50% at 12 mo in New York compared to < 10% due to M. tuberculosis alone, and mortality among HIV-1-infected individuals with multidrug-resistant M. tuberculosis can be as high as 90% at 9 mo (13) . Toosi et al. (14) reported an enhanced susceptibility of blood monocytes from patients with tuberculosis to productive infection with Alveolar macrophages are primary players in host defense phagocytosing M. tuberculosis, and are capable of being infected by HIV-1. At sites of active M. tuberculosis infection, bacilli-laden macrophages may be HIV-infected as well. Infection with M. tuberculosis stimulates the release of mononuclear phagocyte cytokines including IL-1 (IL-fl or a), TNF-a, and 1L-6 in animal models, in in vitro cell culture, and in humans with active tuberculosis (15) (16) (17) (18) (19) (20) (21) (22) (23) . M. tuberculosis up-regulates the genes for these cytokines in peripheral blood monocytes (PBM)1 in vivo from patients with active tuberculosis, and release of these cytokines is enhanced when these cells are cultured in vitro (23, 24) . These cytokines enhance replication of HIV-1 in vitro using several cell lines (25) . The mechanism of this stimulation has been localized to the 5' long terminal repeat (LTR) of HIV-1, and specifically to the nuclear factor (NF)-KB transcription enhancer site (26) (27) (28) (29) (30) (31) (32) (33) . These reagents had been eluted through Detoxi-Gel (Pierce Chemical Co., Rockford IL) columns using sterile, pyrogen-free water, and were stored in pyrogenfree vials from which any contaminating LPS had been removed. Only pyrogen-free water was used in reconstitution of this material. Evaluation of tuberculosis reagents, including LAM, for the presence of gramnegative bacterial endotoxin was done with an Amebocyte lysate assay (E-Toxate kit; Sigma Chemical Co., St. Louis, MO). All lots of LAM, LM, and PIM were tested for LPS contamination and were found to contain < 5 pg of LPS per microgram test reagents.
The pHIVICAT plasmid construct was obtained from Dr. B. M. Peterlin, University of California, San Francisco, CA (34 THP-1 cells were transfected with serially constructed plasmids by the DEAE-Dextran method (35, 36) . Briefly, 107 cells were washed in STBS solution (25 mM Tris, pH 7.4, 137 mM NaCl, 5 mM KCl, 0.6 mM Na2HPO4, 0.7 mM CaCl2, 0.5 mM MgCl2), transfected with 10 mg cesium chloride ultracentrifugation-purified plasmids in 1 ml DEAEDextran solution at 400 ,ug/ml at 37°C for 90 min. The transfected cells were incubated in complete medium for 24 h in the absence or presence of inducing agents. The CAT assays were carried out with commercially available kits from Boehringer Mannheim Biochemicals (Indianapolis, IN). For the assay, the transfected THP-1 cells were broken by three cycles of freeze-thawing. The whole cell extract was heated to 60°C for 10 min and spun in a microfuge for 5 min. The clear supernatant was quantitated for protein concentration with Bio-Rad reagents and 300 Mg protein from each sample was used for the CAT assay. For the CAT assay, 100-Ml cell extracts containing 300 Mg protein were added to wells of rigid flat-bottomed microtiter plates coated with murine mAb to CAT. After incubation of the samples and throughout the wash of the wells, horseradish peroxidase (HRP)-conjugated anti-CAT antibody was added to the test wells. After a second incubation, the excess of the HRP-conjugated antibody was removed by washing. The substrate of HRP was then added, and the color intensity was measured with a microtiter plate reader at 405 nm. The experiments were done in triplicate. The amount of CAT activity was calculated based on a standard curve generated using purified CAT protein. Results represent the means of at least three independent transfections. Within each transfection duplicate samples varied < 10%.
Preparation ofnuclear extracts and DNA mobility shift assay. Cells were prepared from THP-1 cells by using the method first described by Dignam The DNA mobility shift assay was carried out as described by Sen and Baltimore (37) . The NF-KB DNA probe was end-labeled by using polynucleotide kinase in the presence of [y-32P] ATP. The probe (10, (Fig. 2) . The LAM, LM, and PIM were also strong stimuli ranging from 7-to 14-fold over control CAT activity, but the deacylated LAM (Fig. 4 A) . Transient transfection of THP-1 cells, M. tuberculosis stimulation, and CAT assay revealed a fourfold increase using the mutant pHIVICAT reflecting the importance of the NF-KB sites on the LTR. LAM also induced increased CAT activity by wildtype and mutant pHIVICAT, but levels were three-fourths that of live M. tuberculosis, and deacylated LAM was inactive.
Further mutations were performed on pHIVICAT of two NF-1L6 sites (-491/-483, -300/-292) leaving the double NF-KB site intact, and CAT activity after M. tuberculosis stimulation was reduced from 13-fold to 10-fold (Fig. 4 B) . A similar reduction was observed after LAM stimulation. Individual NF-IL6 mutations combined with double NF-KB mutations on pHI-VICAT followed by transient transfection in THP-1 cells and M. tuberculosis stimulation resulted in a 1.8-fold increase in CAT activity for NF-IL6 (5') intact (Fig. 4 C) and 2.5-fold increase in CAT activity for NF-1L6 (3') intact (Fig. 4 D) over control. These data suggest a modest role for NF-IL6 sites in addition to the very striking increase for the double NF-KB motif in mediating 5' LTR transcription after M. tuberculosis or LAM stimulation. Again, there was no increase in activity with decylated LAM.
DNA mobility shift assay demonstrates LAM enhances interaction between nuclear protein(s) and the NF-KB sequence. To determine whether the double NF-KB sequence interacted specifically with nuclear protein(s) after LAM stimulation of THP-1 cells, DNA mobility shift assay was performed. Nuclear proteins isolated from LAM-treated or control THP-1 cells were incubated with end-labeled synthetic double-stranded NF-KB probe in the presence or absence of specific or nonspecific competitors. After treatment with LAM, a dramatically enhanced binding of nuclear protein(s) to the NF-KB site was observed (Fig. 5, lane 2 , compared to unstimulated cells in lane 1) . The protein-DNA interaction was still present after a competition experiment with 100-fold molar excess cold mutated NF-KB probe (Fig. 5, lane 3) . However disease in three patients with AIDS have a striking increase in p24 levels compared to uninvolved sites. Since the saline in BAL fluid dilutes the epithelial lining fluid 100-fold (39), levels of p24 in involved sites may actually be much higher than in plasma consistent with enhanced local HIV-1 replication in vivo. There are at least two mechanisms whereby M. tuberculosis could enhance HIV-1 replication. First, alveolar macrophages could be coinfected, especially at sites of disease where there are large numbers of bacilli where alveolar macrophages are also actively phagocytosing the organism. However, we have demonstrated a very low copy number of HIV-1 DNA in alveolar macrophages from AIDS patients with normal chest radiographs (40) . A second mechanism is for macrophages to be stimulated by M. tuberculosis to release cytokines that enhance HIV-1 replication. In this regard, we have also demonstrated exaggerated release of IL-1p, TNF-a, and 11L-6 from BAL cells into 24-h culture supernatants in vitro from involved sites of patients with pulmonary tuberculosis vs uninvolved sites (41).
The second important finding of our report is that live M. tuberculosis stimulates the HIV-1 LTR, and that this occurs mainly via the cis-acting NF-KB transcription enhancer. We also observed that LAM could also stimulate HIV-1 transcription but was weaker than the live bacilli. Deacylated LAM had no effect on the HIV-1 LTR emphasizing the importance of the inositolphosphate backbone of LAM in producing biologic activity. Alterations of LAM by removing carbohydrate moieties, e.g., lipomannan, or removing glycolipids, e.g., phosphoinositolmannoside, still retained biologic activity (20) . We attempted to dissect the promoter (-640/+81) of the HIV-1 LTR using a plasmid containing double NF-KB and two NF-IL6 sites cloned into pTK.CAT that responded to M. tuberculosis with enhanced CAT activity. Mutations of NF-KB on pHIVICAT revealed a modest amount of CAT increase after M. tuberculosis stimulation which may be due to the two NF-IL6 sites or others (e.g., SPi) but mutations of one or more NF-IL6 sites clearly demonstrated that the majority of the CAT activity increase was due to the double NF-KB site. The mutated NF-KB plasmid was unable to compete for labeled oligonucleotide probe in our electrophoretic mobility shift assay demonstrating inability to bind nuclear proteins and efficacy of the mutations. The consensus sequence for NF-IL6 5 ' T(T/G)NNGNAA(T/G) 3 (IL-1,B, IL-6, IL-8, TNF-a) , albumin, c-fos, G-CSF, and several viral proteins (44) . It is possible that the enhanced transcription of the HIV-1 LTR by M. tuberculosis is due to synergistic interaction of NF-IL6 and NF-KB because mutation of one or the other sites reduced CAT activity. NF-IL6a and [3 are members of the CCAAT/enhancer binding protein (C/EBP) family of transcription factors (C/ EBPQ and C/EBP6, respectively). Cooperative binding of NF-KB and C/EBP to their adjacent binding sites has been demonstrated on the IL-8 promoter (45) . We propose that similar to IL-8 and IL-6, NF-KB plays the more important role in HIV-1 LTR gene regulation but that its activity may be enhanced by C/EBPP. Further, C/EBPP specifically bound to and activated the TNF-a promoter at a site that C/EBPa could not bind to (46) . A dominant negative version of C/EBP/3 blocked TNFa promoter activation in myeloid cells (46) .
The NF-KB transcription-enhancer element on the HIV-1 LTR is responsive to the cytokines IL-1, TNF-a and IL-6 (26-30, 47-49). All three of these cytokines are also stimulated in vitro in PBM by M. tuberculosis and its components, especially LAM ( 16, (18) (19) (20) 22) . Although these cytokines may only be transiently released in the blood, we have demonstrated upregulation of the mRNA for these cytokines in PBM from HIVactive tuberculosis patients compared to normal controls (24) . Denis and Ghadirian recently demonstrated that alveolar macrophages lavaged from HIV+ individuals spontaneously released more IL-1I3, TNF-a, and IL-6 than normal controls, and infecting these macrophages in vitro with M. avium augmented cytokine release (50) . Importantly, they coinfected alveolar macrophages in vitro with HIV-1 and M. avium finding higher reverse transcriptase activity from dually infected experiments than HIV-1 alone over a 5-15-d culture period. In addition to cytokines, the activation of the HIV promoter in the viral LTR has been observed by mitogens, phorbol esters, retinoic acid, ionizing radiation (51 ), ultraviolet light (52), T3 receptor (53 ) , and viruses (herpes virus, cytomegalovirus, human T lymphocyte virus-i [54] , papovaviruses and others) (29, 30) . We demonstrated that more than half of the stimulation of the HIV-1 LTR by M. tuberculosis could be blocked by the combined use of anti-TNF-a, anti-IL-la, and anti-IL-l/3 suggesting roles for these cytokines in stimulation (26) . 1L-6 also has been reported to synergize with TNF-a in the induction of latent HIV-1 expression by acting both at transcription and posttranscriptionally (47). HIV-1 in human alveolar macrophages is latent in vivo but replicates after in vitro stimulation over 6 d in the presence of TNF-a and GM-CSF (55). Although we have focused on the mononuclear phagocyte, dendritic cells in the lung are also a reservoir for HIV-1 infection, and are a major presentor of M. tuberculosis antigens to T lymphocytes (56) . Coinfection of these cells may cause further disarray of the host immune defense. Whalen et al. recently reported that dually infected HIV+/tuberculosis patients matched by CD4+ counts to HIV+ patients have a significantly reduced 1 yr survival (65% vs 90%, P = 0.0) (57) .
In summary, M. tuberculosis and its components may activate HIV-1 replication through enhanced transcription of the LTR via the NF-KB motif which may be modulated by C/EBP,6
(NF-IL-6a), and the cytokines, TNF-a and IL-1,/, are partially responsible for this effect. Therapeutic strategies using negative regulators, e.g., thalidomide to block TNF-a, or activating cytotoxic T cells, may be useful in modulating effects of the dual
